Patent · US Active

Frigostable composition for iontophoretic transdermal delivery of a triptan compound

US11464760B2 · kind B2 · utility

0Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2018
Grant dateOct 11, 2022
Priority date
Expiry dateDec 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to frigostable compositions suitable for iontophoretic transdermal delivery of a triptan compound that includes: a salt of a triptan compound, preferably sumatriptan succinate, a polyamine, one or more dicarboxylic acids, 0.5 to 10.0 wt.-% (based on the total weight of the composition) of one or more monocarboxylic acids, and water or an aqueous solvent mixture. The invention further relates to the use of the composition as an integral component of an iontophoretic patch, preferably as an anodic reservoir of the patch.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.